Jul 14, 2014, 00:00 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC, UNITED STATES - Jul 14, 2014 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today the expansion of its drug design and development program

Jul 11, 2014, 10:25 AM by Michael Croft

Bio-IT World News Brief | This Wednesday, American Gut, the crowdsourced project that has now sequenced gut microbiota samples from over 3,000 volunteers, released both a round of results and its own analytical pipeline.

Jul 11, 2014, 00:00 AM by Michael Croft

LONDON, UNITED KINGDOM - Jul 11, 2014 - Leading sample management software provider, Titian Software (www.titian.co.uk), has announced that it will be introducing Mosaic Assay Requesting - a major new module that integrates fully with the highly regarded Mosaic sample management software suite

Jul 10, 2014, 14:55 PM by Michael Croft

Bio-IT World | Today, the leadership of the Human Brain Project circulated a document responding to this Monday's open letter to the European Commission, in which neuroscientists aired concerns about the aims and decision-making processes behind the HBP.

Jul 10, 2014, 10:00 AM by Michael Croft

Bio-IT World News Brief | The Amazon Web Services Cloud Summit kicked off with a keynote from Werner Vogels, Chief Technology Officer. Vogels announced CloudWatch Logs to monitor the system and application logs for trends and events over time, and highlighted the work of the Novartis Institutes for Biomedical Research using a 2014 Bio-IT World Best of Show winner.

Jul 10, 2014, 08:00 AM by Michael Croft

U-T San Diego | The rumored merger of the Scripps Research Institute in La Jolla and the University of Southern California is off, the Scripps board of trustees said yesterday

Jul 9, 2014, 12:00 PM by Michael Croft

Wall Street Journal | In an oped in the Wall Street Journal, Francis Collins gives his view of the "broad horizon" before biomedical research today.

Jul 9, 2014, 12:00 PM by Michael Croft

Bio-IT World News Brief | If you’ve got an idea for a next-gen sequencing analysis pipeline—and you’re creative on camera—Appistry invites you to participate in its inaugural Appistry Pipeline Challenge. The winning group will receive $70,000 worth of hardware and software to build its pipeline.

Jul 9, 2014, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Jul 9, 2014 - The Intellectual Property and Science business of Thomson Reuters,  the world’s leading provider of intelligent information for businesses and professionals, today released a three-part analysis on the depression drug market following the 25th anniversary of the U

Jul 8, 2014, 08:00 AM by Michael Croft

New York Times | AbbVie raised its bid for Shire this morning to a cash and stock offering worth about $87.66 per share, or $51.6 billion total.

Jul 8, 2014, 00:00 AM by Michael Croft

BOSTON, MA - Jul 8, 2014 - Boston Children's Hospital today announced the creation of two new annual awards that will be conferred at the Global Pediatric Innovation Summit + Awards, Taking on Tomorrow  (#PedInno14), taking place October 30-31, 2014, at the Seaport World Trade Center in Boston

Jul 8, 2014, 00:00 AM by Michael Croft

CHARLOTTESVILLE, VA, UNITED STATES - Jul 8, 2014 - FOR IMMEDIATE RELEASE   Study of InSpark Technologies' Pattern Identification System Published in the Journal of Diabetes Science and TechnologyData demonstrates the utility of InSpark's advanced blood glucose pattern recognition technology

Jul 7, 2014, 11:35 AM by Michael Croft

Bio-IT World | This morning, the European Commission received an open letter signed by 154 European neuroscientists, expressing concern over the direction of the Human Brain Project that was launched last year.

Jul 7, 2014, 00:00 AM by Michael Croft

CAMBRIDGE, MA - Jul 7, 2014 - NextCODE Health, which puts whole-genome analysis in the hands of clinicians and researchers worldwide, today announced the start of a partnership with the Academic Centre on Rare Diseases (ACoRD) at University College Dublin

Jul 3, 2014, 12:00 PM by Michael Croft

South China Morning Post | The China Food & Drug Administration approved two sequencers from BGI--the BGISEQ-1000 and BGISEQ-100--and a diagnostic kit for prenatal testing of "high risk" pregnancies.

Jul 3, 2014, 12:00 PM by Michael Croft

Bio-IT World | Guest Commentary | The global pharmaceutical industry faces challenges that require it to look beyond the status quo and develop a fresh transformative vision for the future. Many pharmas are now looking to consolidate vendors as they embark on restructuring and cost reduction efforts.

Jul 3, 2014, 12:00 PM by Michael Croft

NBC News | Yesterday the National Institutes of Health launched the Undiagnosed Diseases Network, a four-year, $43 million program focused on the rarest of diseases, many afflicting fewer than 50 people worldwide.

Jul 1, 2014, 07:10 AM by Michael Croft

Bio-IT World | Euretos is certainly not the first company to recognize the problems researchers have processing and keeping up to date with the latest research. While there’s ever more data pouring from researchers’ lab instruments, there’s also an ongoing flow to manage from journals and other publications. Euretos has launched a cloud platform called BRAIN: the Bio Relations and Intelligence Network, that allows researchers to mine and connect data from public and private published sources in new ways.

Jul 1, 2014, 06:00 AM by Michael Croft

Bio-IT World | Outsourcing options in biotech have been growing. CROs and other labs offer a wide range of services. But what if you aren’t interested in a partner as much as simply automated experiments? Don’t outsource experiments to another lab; let the robots do them!

Jul 1, 2014, 00:00 AM by Michael Croft

REDWOOD SHORES, CA, UNITED STATES - Jul 1, 2014 - Model N, Inc. (NYSE: MODN), the leading revenue management provider to the life sciences and technology industries, today announced the expansion of the Model N Regulatory Update Program - a program that every Model N Government Compliance customer is automatically enrolled in at no extra charge